Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
6GspmbJDjq2XVsR1
